Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VORAPAXAR vs VORICONAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VORAPAXAR vs VORICONAZOLE: Safety Overview

Metric VORAPAXAR VORICONAZOLE
Total FAERS Reports 189 14,384
Deaths Reported 12 3,940
Death Rate 6.3% 27.4%
Hospitalizations 45 5,118
Average Patient Age 66.2 yrs 52.8 yrs
% Female Patients 30.6% 38.3%
FDA Approval Date May 8, 2014 Apr 13, 2016
Manufacturer N/A Xellia Pharmaceuticals USA LLC
Route N/A INTRAVENOUS
Marketing Status Discontinued Prescription